Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study

OBJECTIVE: To evaluate upadacitinib efficacy and safety dose response in Japanese patients with active RA and an inadequate response to conventional synthetic DMARDs (csDMARDs). METHODS: This was a multicentre, phase IIb/III, dose-ranging study conducted in Japan, in which patients on previously sta...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Rheumatology (Oxford)
Hlavní autoři: Kameda, Hideto, Takeuchi, Tsutomu, Yamaoka, Kunihiro, Oribe, Motohiro, Kawano, Mitsuhiro, Zhou, Yijie, Othman, Ahmed A, Pangan, Aileen L, Kitamura, Susumu, Meerwein, Sebastian, Tanaka, Yoshiya
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Clinical Science
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7590414/
https://ncbi.nlm.nih.gov/pubmed/32277824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa084
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky